Cargando...
Histologic transformation of lung cancer during pembrolizumab therapy: A case report
Immune checkpoint inhibitors that block the programmed death 1/programmed death ligand 1 pathways are widely used to treat advanced lung cancers. There are seldom cases of histologic transformation reported after treatment with immunotherapy. Here, we report the case of a 69‐year‐old man with stage...
Guardado en:
| Autores principales: | , , , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Wiley
2020-03-01
|
| Colección: | Thoracic Cancer |
| Materias: | |
| Acceso en línea: | https://doi.org/10.1111/1759-7714.13312 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|